中点能源美股招股说明书(2025-05-27版)

CenterPoint Energy, Inc. The forward sellers referred to below are offeringshares of our common stock, par value $0.01 per share. We expect to enter into separate forward saleagreements with each of Bank of America, N.A., Mizuho Markets Americas LLC (with Mizuho Securities USA LLC acting as agent) and JPMorgan Chase Bank, from such election, and we may owe cash to the relevant forward purchaser. If we elect to net share settle all or a portion of a forward sale agreement, we will notreceive any cash proceeds from such election, and we may owe shares of our common stock to the relevant forward purchaser. See “Underwriting (Conflicts ofInterest)—Forward Sale Agreements” for a description of the forward sale agreements.Our common stock is listed on The New York Stock Exchange (the “NYSE”) and the NYSE Texas, in each case, under the symbol “CNP.” On May23, 2025, the last reported sale price of our common stock on the NYSE was $37.57 per share. accompanying prospectus.PerSharePublic Offering Price$Underwriting Discount$Proceeds, before expenses, to CenterPoint Energy, Inc. (1)$(1)We expect to receive estimated net proceeds from the sale of shares of our common stock, before expenses, of approximately $(or approximatelyif the underwriters’ option to purchase additional shares of our common stock is exercised in full, and we elect to have the forward sellers borrow and “Underwriting (Conflicts of Interest)—Forward Sale Agreements” for a description of the forward sale agreements.We have granted the underwriters an option for a period of 30 days from the date of this prospectus supplement to purchase up to an additional $120,000,000 ofshares of our common stock at a price of $per share, subject to certain possible adjustments, to cover sales by the underwriters in the initial offering of theshares of our common stock or in the open market of a greater number of shares of our common stock than the total number set forth above. If such option is exercised,we may, in our sole discretion, enter into additional forward sale agreements with each of the forward purchasers in respect of the number of shares of our commonstock that are subject to the exercise of such option. Unless the context requires otherwise, the term “forward sale agreements” as used in this prospectus supplementincludes any additional forward sale agreements that we may enter into with a forward purchaser in connection with the exercise by the underwriters of their option. Ifsuch option is exercised and we elect not to enter into additional forward sale agreements, we have agreed to issue and sell directly to the underwriters the number ofshares of our common stock that are subject to the exercise of such option. If we enter into additional forward sale agreements, and if in the good faith, commerciallyreasonable judgment of a forward purchaser, it or its affiliate is unable to borrow, or is unable to borrow at a stock loan rate no greater than a specified rate, and deliver The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectussupplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy thesesecurities in any jurisdiction where the offer or sale is not permitted.The underwriters expect that shares of our common stock will be delivered against payment on or about May, 2025.Joint Book-Running Managers CitigroupRBCCapitalMarketsMay, 2025 this offering together with the additional information described in the accompanying prospectus under the heading “Where You Can Find MoreInformation” and in this prospectus supplement under the headings “Where You Can Find More Information” and “Incorporation By Reference.” If thedescription of our capital stock varies between this prospectus supplement and the accompanying prospectus, you should rely on the information in thisprospectus supplement. make any representations other than those contained or incorporated by reference in this prospectus supplement, the accompanying prospectus and anywritten communication prepared by us or on our behalf. We and the underwriters, the forward purchasers and the forward sellers take no responsibilityfor, and can provide no assurance as to the reliability of, any other information that others may give you. We are not, and the underwriters, the forwardpurchasers and the forward sellers are not, making an offer to sell our common stock and are not soliciting an offer to buy our common stock in any jurisdiction where the offer or sale is not permitted. The information we have included in this prospectus supplement or the accompanying prospectus isaccurate only as of the date of this prospectus supplement or the accompanying prospectus, as the case may be, and any information we haveincorporated by reference is accurate only as of the date of the document incorporated by reference. Our businesses, financial condition, results ofoperations and pros